Immunohistochemical expression of glutathione S-transferase-π can predict chemotherapy response in patients with nonsmall cell lung carcinoma

Cancer

Volumn 78, Issue 3, 1996, Pages 416-421

  Bai, Fen ^a   Nakanishi, Yoichi ^a   Kawasaki, Masayuki ^a   Takayama, Koichi ^a   Yatsunami, Jun ^a   Pei, Xin Hai ^a   Tsuruta, Nobuko ^a   Wakamatsu, Kentaro ^a   Hara, Nobuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

chemotherapeutic response; cisplatin; glutathione S transferase ; immunohistochemical staining; nonsmall cell lung carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL; GLUTATHIONE TRANSFERASE; VINDESINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 0029895149     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960801)78:3<416::AID-CNCR6>3.0.CO;2-H     Document Type: Article

References (36)

1. von Hoff DD, Clark GM, Stogelill BJ, Sarcosdy MF, O'Brien MT, Casper JT, et al. Prospective clinical trial of a human tumor cloning system. Cancer Res 1983;43:1926-31.
2. Bertelsen CA, Sondak VK, Mann BD, Korn EL, Kern DH. Chemosensitivity testing of human solid tumors. Cancer 1984;53:1240-5.
3. Pastan I, Gottesman M. Multiple-drug resistance in human cancer. N Engl J Med 1987;316:1388-93.
4. Clapper ML, Buller AL, Smith TM, Tew KD. Glutathione S-transferases in alkylating agent resistant cells. In: Mantle TJ, Pickett CB, Hayes JD, editors. Glutathione S-transferases and carcinogenesis. London: Taylor and Francis, 1987:213-24.
5. Dahllof B, Martinsson T, Mannervik B, Jensson H, Levan G. Characterization of multidrug resistance in SEWA mouse tumor cell: increased glutathione transferase activity and reversal of resistance with verapamil. Anticancer Res 1987; 7:65-9.
6. Wolf CR, Lewis AS, Carmichael J, Ansell J, Adams DJ, Hickson IJ, et al. Glutathione S-transferase expression in normal and tumour cells resistant to cytotoxic drugs. In: Mantle TJ, Pickett CB, Hayes JD, editors. Glutathione S-transferases and Carcinogenesis. London: Taylor and Francis, 1987:199-212.
7. Ozols RF, Odwyer PJ, Hamilton TC, Young RC. The role of glutathione in drug resistance. Cancer Treat Rev 1990;17:45-50.
8. Wolf CR, Lewis AD, Carmichael J, Allan SG, Ansell DJ. The role of glutathione in determining the response of normal and tumor cells to anticancer drugs. Biochem Soc Trans 1987;15:728-30.
9. Muhktar H, Bresnick E. Glutathione-S-epoxide transferase activity during development and the effect of partial hepatectomy. Cancer Res 1976;36:937-40.
10. Clifton G, Kaplowitz N. The glutathione S-transferases of the small intestine in the rat. Cancer Res 1977;37:788-91.
11. Mannervi KB, Alin P, Guthenberg C, Jennson H, Tahir MK, Warholm M, et al. Mammalian species: correlation between structural data and enzymatic properties. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA 1985;82:7202-6.
12. Meyer JD, Coles B, Pemble SE, Gilmore KS, Fraser GM, Ketterer B. GSTθ, a new class of glutathione transferases purified from rat and man. Biochem J 1991;274:409-14.
13. Howie AF, Forrester LM, Glancey MJ, Schlager JI, Powis G, Beckett GJ, et al. Glutathione S-transferase and glutathione peroxidase expression in normal and tumor human tissues. Carcinogenesis 1990;11:451-8.
14. Okuyama T, Maehara Y, Endo K, Baba H, Adachi Y, Kuwano K, et al. Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin. Cancer 1994;74:1230-6.
15. Hida T, Kuwabara M, Ariyoshi Y, Takahashi T, Sugiura T, Hosoda K, et al. Serum glutathione S-transferase-π level as a tumor marker for non-small cell lung cancer. Potential predictive value in chemotherapeutic response. Cancer 1994;73:1377-82.
16. Eimoto H, Tsutsumi M, Nakajima A, Yamamoto K, Takashima Y, Maruyama H, et al. Expression of the glutathione S-transferase placental form in human lung carcinomas. Carcinogenesis 1988;9:2325-7.
17. Chung H, Chieh HH, Hu H, Tsa C. Immunohistochemical investigation on the expression of glutathione S-transferases (GSTS) in lung cancer. Chin J Tubercul Respir Dis 1993; 16:141-3.
18. World Health Organization. Histological typing of tumors. Tumori 1981;67:253-72.
19. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results on cancer treatment. Cancer 1981;47:207-11.
20. Gilbert L, Elwood LJ, Merino M, Masood S, Barnes R, Steinberg SM, et al. A pilot study of π-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 1993;11:49-58.
21. Hamaga SI, Kamada M, Furumoto H, Hirao T, Aono T. Expression of glutathione S-transferase-π in human ovarian cancer as an indicator of resistance to chemotherapy. Gynecol Oncol 1994;52:313-9.
22. Hida T, Ariyoshi Y, Kuwabara M, Sugiura T, Takahashi T, Takahashi T, et al. Glutathione S-transferase π levels in a panel of lung cancer cell lines and its relation to chemoradiosensitivity. Jpn J Clin Oncol 1993;23:14-9.
23. Zwelling LA, Kohn KW. Effects of cisplatin on DNA and the possible relationships to cytotoxicity and mutagenicity in mammalian cells. In: Prestayko A, Crooke S, Carter S, editors. Cisplatin: current status and new developments. New York: Academic Press, 1980:21-37.
24. Gately DP, Hawell SB. Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 1993;67:1171-6.
25. Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS. Overexpression of metallothioneine confers resistance to anticancer drugs. Science 1988;241:1813-5.
26. Masuda H, Tanaka T, Matsuda H, Kusaba I. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis Diamminedichloroplatinum (II). Cancer Res 1990;50:1863-6.
27. Waxman DJ. Glutathione S-Transferases: role in alkylating agent resistance and possible target for modulation chemotherapy-a review. Cancer Res 1990;50:6449-54.
28. Jakoby WB. The glutathione S-transferases: a group of multifunctional detoxification proteins. Adv Enzymol Relat Areas Mol Biol 1978;46:383-414.
29. Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR. The relationship between glutathione, glutathione S-transferase and cytotoxicity of platinum drug and melphalan in eight human ovarian carcinoma cell lines. Br J Cancer 1991;64:215-20.
30. Sharma R, Singhal SS, Srivastava SK, Bajpai KK, Frenkel EP, Awasthi S. Glutathione linked enzymes in human small cell lung cancer cell lines. Cancer Lett 1993;75:111-19.
31. Green JA, Robertson LJ, Clark AH. Glutathione S-transferase expression in benign and malignant ovarian tumors. Br J Cancer 1993;68:235-9.
32. van der Zee AGJ, Hollema H, Suurmeijer AJH, Krans M, Sluiter WJ, Willemse PHB, et al. Value of P-glycoprotein, glutathione S-transferase pi, c-erbE-2, and p53 and prognostic factors in ovarian carcinomas. J Clin Oncol 1995;13:70-8.
33. Murphy D, Mcgown AT, Hall A, Cattan A, Crowther D, Fox BW. Glutathione S-transferase activity and isoenzyme distribution in ovarian tumor biopsies taken before or after cytotoxic chemotherapy. Br J Cancer 1992;66:937-42.
34. Tidefelt U, Elmhorn RA, Paul C, Hao XY, Mannervik B, Eriksson LC. Expression of glutathione transferase π as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia. Cancer Res 1992;52:3281-5.
35. Mannervi KB, Castro VM, Danielson UH, Tahir MK, Hansson J, Ringborg U. Expression of class pi glutathione transferase in human malignant melanoma cells. Carcinogenesis 1987;8:1929-32.
36. Gonzalez BM, Garcia GC, Zamora P, Garcia de PML, Feliu J, Ordonez A, et al. Non-small-cell lung cancer (NSCLC): chemotherapy in advanced disease. Our experience in ten years. Am J Clin Oncol 1992;15:23-8.